-
Gasdermin C Drives PDAC Stemness and Immune Evasion
2026-10-08
A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a transcriptionally active regulator of pancreatic ductal adenocarcinoma stemness, metastasis, and immune evasion through a mechanism independent of classical pyroptosis. The findings position ADAM17-dependent cleavage, GSDMC nuclear localization, and CXCL9-associated immune remodeling as preclinical targets for improving responses to KRASG12D inhibition and PD-1 blockade.
-
Disulfiram: Reading Evidence Across Cell Death Pathways
2026-10-07
Disulfiram is more than a dopamine β-hydroxylase inhibitor: its reported effects span aldehyde metabolism, copper-associated proteasome biology, apoptosis, and GSDMD-linked pyroptosis. This evidence-focused analysis separates established findings from mechanistic interpretation and explains what the NU6300 study contributes to cancer and inflammation research.
-
GSDMC Drives PDAC Stemness Beyond Pyroptosis
2026-10-07
A 2024 Advanced Science study identifies Gasdermin C as a nuclear regulator of pancreatic ductal adenocarcinoma stemness, metastasis, and immune evasion rather than only a pore-forming pyroptosis protein. Its findings connect ADAM17-dependent cleavage and nuclear GSDMC activity with CXCL9-linked immune remodeling and improved responses to KRASG12D inhibition and PD-1 blockade, while leaving important translational questions unresolved.
-
SM-102 in mRNA-LNP Research: Evidence and Limits
2026-10-06
SM-102 is a synthetic lipid associated with lipid nanoparticle mRNA delivery, but the strongest supplied evidence concerns assay design rather than SM-102-specific performance. This overview examines how cell line, reporter gene and analytical readout influence apparent transfection, and explains why in-vitro findings should not be treated as direct evidence of clinical efficacy, safety or formulation superiority.
-
Palmitic Acid (N2456): Product Overview
2026-10-06
Palmitic acid, also called hexadecanoic acid, is a supplier-documented saturated long-chain fatty acid. APExBIO lists SKU N2456 with defined chemical identity and 98% stated purity; no matched paper evidence was provided for product-specific performance or outcomes.
-
Ivermectin and GSDMC: Translational Boundaries
2026-10-05
The 2024 GSDMC study in pancreatic ductal adenocarcinoma offers a compelling framework for understanding stemness, immune evasion, and therapeutic resistance, but it does not establish an oncology role for Ivermectin. This thought-leadership article separates validated GSDMC biology from speculative drug repurposing and outlines a biomarker-led path for translational researchers.
-
Ribociclib and Acid-Reducing Agents: QbD Evidence
2026-10-04
A Journal of Chromatographic Science study used a Quality by Design analytical strategy and biorelevant micro-dissolution modeling to examine whether pH shifts could alter ribociclib succinate behavior. Although solubility decreased after modeled gastric-to-intestinal pH transitions, the authors concluded that the observed changes did not indicate a significant effect on absorption, while emphasizing the need to distinguish in vitro findings from clinical pharmacokinetic evidence.
-
Proteinase K in Molecular Biology: Evidence and Limits
2026-10-03
Proteinase K is a broad-spectrum serine protease widely described for protein hydrolysis and enzyme contaminant removal in nucleic-acid workflows. This overview separates supplier claims from published biological evidence, explains its conceptual relevance to extracellular-vesicle research, and examines limitations involving DNA integrity, protease accessibility, model transferability, and study provenance.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody
2026-10-02
HRP Goat Anti-Rabbit IgG (H+L) Antibody provides an affinity-purified, enzyme-labeled detection reagent for rabbit IgG primary antibodies in Western blotting, ELISA, IHC, and ICC. It is intended for research workflows that need HRP-based signal generation, but it should not be used as a diagnostic reagent or treated as validated for a specific assay dilution without local optimization.
-
KDM4A in Malignant Pleural Mesothelioma
2026-10-01
The reference study identifies the histone lysine demethylase KDM4A as an important growth dependency in malignant pleural mesothelioma (MPM). By combining expression analysis, genetic and pharmacological inhibition, xenograft experiments, and pathway profiling, the authors define KDM4A-linked vulnerabilities involving apoptosis, DNA repair, CHK1, and WEE1.
-
Grazoprevir hydrate: From Target to Assay
2026-10-01
Grazoprevir hydrate, also known as MK-5172 hydrate, is examined from NS3/4A target engagement through genotype-aware assay design. This evidence-led guide connects antiviral mechanism, clinical pharmacology, resistance interpretation, and reproducible research workflows.
-
Leucomycin Activity and Macrolide Resistance
2026-09-30
The 1962 study systematically examined leucomycin, particularly its A1 fraction, against a broad panel of pathogenic and antibiotic-resistant bacteria. Its value lies in combining spectrum testing with comparisons across pH, blood-containing media, and multiple susceptibility formats, providing a useful historical framework for bacterial infection research and macrolide resistance studies.
-
CHIR-99021 (CT99021): GSK-3 Inhibition
2026-09-30
CHIR-99021, also called CT99021, is a selective GSK-3α/β inhibitor used to modulate Wnt/β-catenin signaling and stem-cell state. Its strongest research applications include embryonic stem cell pluripotency maintenance and directed cardiomyogenic differentiation, while assay-specific dosing and pathway context determine outcomes.
-
Fludarabine Workflows for DNA Synthesis Studies
2026-09-29
Build reproducible leukemia and multiple myeloma assays around Fludarabine, a DNA synthesis inhibitor that connects cell-cycle arrest with measurable apoptosis. A second use case extends the workflow into lymphodepletion and neoantigen-presentation studies, while keeping direct drug toxicity distinct from T-cell-mediated killing.
-
EdU Imaging Kits (Cy5): Practical Workflow
2026-09-29
EdU Imaging Kits (Cy5) provide a practical way to measure DNA synthesis in S-phase cells by combining EdU incorporation with Cy5 click-chemistry detection. They are suitable for fluorescence microscopy and flow cytometry, but the assay should not be treated as a direct measurement of viability, total cell number, or completed cell division.